Skip to main content
. 2018 Jan 8;53(8):907–915. doi: 10.1007/s00535-017-1426-y

Table 4.

Comparison of clinical findings of CEAS patients by c.940 + 1G > A mutation

c.940 + 1G > A homozygotes group (n = 17) Non-c.940 + 1G > A homozygotes group (n = 29) p*
Age at diagnosis (years, median) 38 42.5 NS
Age at onset (years, median) 14 19 NS
Symptoms
 Abdominal pain 8 (47%) 10 (34%) NS
Disease site
 Stomach 4 (24%) 8 (28%) NS
 Duodenum 11 (65%) 11 (38%) NS
 Jejunum 3 (18%) 11 (39%) NS
 Ileum (except for terminal ileum) 16 (94%) 28 (100%) NS
Laboratory data at diagnosis
 Hemoglobin (g/dl, median) 10.7 (4.8–13.5) 9.4 (2.3–13.7) NS
 Serum protein (g/dl, median) 5.4 (1.2–8.2) 5.0 (2.7–7.0) 0.03
 CRP (g/dl, median) 0.20 (0–1.6) 0.20 (0–1.1) NS
Surgery 11 (65%) 18 (62%) NS
Extra-intestinal manifestations
 Digital clubbing 3 (18%) 7 (24%) NS
 Periostosis 4 (24%) 7 (26%) NS
 Arthralgia of large joints 4 (24%) 3 (10%) NS
 Pachydermia 4 (24%) 4 (14%) NS

NS not significant

A significant p value is indicated in bold

* Fisher’s exact test or Mann–Whitney U test

Data are available for 45 patients